Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?

Kartik Gupta, Shane P. Prejean, Muthiah Vaduganathan, Harsh Golwala, Thomas Evan Watts, Sudeep R. Aryal, Gregory von Mering, Oscar Julian Booker, Mustafa I. Ahmed, Navkaranbir S. Bajaj

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number100404
JournalIJC Heart and Vasculature
StatePublished - Sep 2019


  • Antithrombotic therapy
  • Atrial fibrillation
  • Bleeding
  • Percutaneous coronary intervention
  • Stent thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this